Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2011
11/15/2011US8058274 Heterocycles as potassium channel modulators
11/15/2011US8058266 Methods and compositions for treatment of macular and retinal disease
11/15/2011US8058210 Arylphenyl-substituted cyclic keto-enols
11/15/2011US8057920 Heterocyclic compound and organic light emitting device comprising the same
11/15/2011CA2690111C Anthelmintic combination
11/15/2011CA2598690C Small molecule inhibitors of mdm2 and uses thereof
11/15/2011CA2505489C Pyrrolobenzodiazepines
11/15/2011CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/10/2011WO2011140488A1 Pyridone and aza-pyridone compounds and methods of use
11/10/2011WO2011139273A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors
11/10/2011WO2011138743A1 Use of pyromellitic diimides in organic electronics and organic photovoltaics
11/10/2011WO2011138307A1 Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk
11/10/2011WO2011137951A1 Organic electroluminescence devices
11/10/2011WO2011137587A1 Cytokine inhibitors
11/10/2011WO2011084433A3 Aza-bridged ring-fused indoles and indolines
11/10/2011WO2011082269A3 Substituted benzo-pyrimido-tetrazolo-diazepine compounds
11/10/2011US20110275814 Material for organic electroluminescence device and organic electroluminescence device
11/10/2011US20110275809 Process for the preparation of n-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-n-methyl-acetamide
11/10/2011US20110275808 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
11/10/2011US20110275807 Application of Evodiamine in preparing medicaments for Alzheimer's disease
11/10/2011US20110275801 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/10/2011US20110275799 PROCESS FOR THE SYNTHESIS OF 4H-IMIDAZO [1,5-a] [1,4] BENZODIAZEPINES, IN PARTICULAR MIDAZOLAM AND SALTS THEREOF
11/10/2011US20110275651 Fused ring heteroaryl kinase inhibitors
11/10/2011US20110275613 Organic compounds
11/10/2011US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/10/2011US20110275609 Bicyclic pyrazolo-heterocycles
11/10/2011US20110275588 Fused Diimidazodiazepine Compounds and Methods of Use and Manufacture Thereof
11/10/2011US20110272688 Aryl-aryl dendrimers
11/10/2011US20110272685 Materials for organic electroluminescence devices
11/10/2011US20110272684 Materials for organic electroluminescence devices
11/10/2011CA2761074A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors
11/09/2011EP2385053A2 Intermediates for the preparation of fused bicyclic mTOR inhibitors
11/09/2011EP2385042A1 Prokineticin 1 receptor antagonists
11/09/2011EP2385040A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
11/09/2011EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011EP2385038A1 Dimeric IAP inhibitors
11/09/2011EP2384756A2 High-purity large-scale preparation of stannsoporfin
11/09/2011EP2384328A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
11/09/2011EP2384327A1 Fused ring compound and use thereof
11/09/2011EP2384326A1 Pyrrolo[2,3-d]pyrimidine compounds
11/09/2011EP2078022B1 Spiro benzazepines used as vasopressin antagonists
11/09/2011EP2069353B1 Polycyclic agents for the treatment of respiratory syncytial virus infections
11/09/2011EP2018383B1 Triazolopyrazine derivatives useful as anti-cancer agents
11/09/2011EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011EP1786812B1 Pyridine methylene azolidinones and their use as phosphoinositide inhibitors
11/09/2011EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011EP1430061B1 Inclusion compound comprising cucurbituril derivatives as host molecule and pharmaceutical composition comprising the same
11/09/2011CN1938309B CRF receptor antagonists and methods relating thereto
11/09/2011CN1934113B Compositions useful as inhibitors of protein kinases
11/09/2011CN1873396B Water detection indicator
11/09/2011CN102239172A Hiv整合酶抑制剂 Hiv integrase inhibitors
11/09/2011CN102239169A Crystalline forms
11/09/2011CN102239146A Novel compounds as calcium channel blockers
11/09/2011CN101684101B Piperazinone substituted tetracycline derivatives
11/09/2011CN101273040B Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists
11/08/2011US8053576 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
11/08/2011US8053574 Organic compounds
11/08/2011US8053571 Methods, compositions, and apparatuses for forming macrocyclic compounds
11/08/2011US8053434 Kinase inhibitors and their uses
11/08/2011US8053428 Vinorelbine derivatives
11/05/2011CA2817112A1 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
11/03/2011WO2011137155A1 Imidazopyridazinyl compounds and their uses for cancer
11/03/2011WO2011136483A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
11/03/2011WO2011136385A1 Bicyclic compound derivatives and their use as acc inhibitors.
11/03/2011WO2011136384A1 A process of a quaternary ammonium salt using phosphate
11/03/2011WO2011136383A1 A process of a quaternary ammonium salt
11/03/2011WO2011135491A1 Herbicidal azolopyrimidines
11/03/2011WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011WO2011134925A1 Spiroindolinone pyrrolidines
11/03/2011WO2011134877A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/03/2011WO2011134867A1 Herbicidal azolopyrimidines
11/03/2011WO2011134831A1 Pyrazole compounds as jak inhibitors
11/03/2011WO2011134019A1 Novel biphenyl sartans
11/03/2011WO2011112689A3 Salts of an indazolylpyrrolotriazine
11/03/2011WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011US20110269972 Novel tricyclic chiral compounds and their use in asymmetric catalysis
11/03/2011US20110269960 Triazole derivative
11/03/2011US20110269809 Spiroindolinone pyrrolidines
11/03/2011US20110269778 Novel diphenyl purine derivatives useful as modulators of nicotinic acetylcholine receptors
11/03/2011US20110269772 Axl kinase inhibitors
11/03/2011US20110269751 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
11/03/2011US20110269744 Benzazepine Compound
11/03/2011US20110269740 Jak kinase modulating compounds and methods of use thereof
11/03/2011US20110269714 Polycyclic Tetracycline Compounds
11/03/2011US20110268699 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
11/03/2011US20110266528 Substituted carbazole derivatives and use thereof in organic electronics
11/03/2011CA2797772A1 Pyrazole compounds as jak inhibitors
11/03/2011CA2794824A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/02/2011EP2382218A1 Delta-5-desaturase inhibitors
11/02/2011EP2382210A2 Pyrimidinediamine kinase inhibitors
11/02/2011EP2382207A2 Pi3k/mtor kinase inhibitors
11/02/2011EP2382191A1 Novel benzenesulfonamides as calcium channel blockers
11/02/2011EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011EP2381772A1 Process and intermediates for the preparation of n-acylated-4-aryl beta-amino acid derivatives
11/02/2011EP2278977B1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
11/02/2011EP2278973B1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
11/02/2011EP2245014B1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/02/2011EP2007767B1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors
11/02/2011EP1931735B1 High-purity texaphyrin metal complexes
11/02/2011EP1924585B1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative